In this episode, the discussants examines the following questions, raised after a Journal of Hepatology’s nomenclature article:

  • Is the introduction of metabolic risk factors (MRF) for the definition of MASLD justified?
  • What are the main issues regarding the measurement and thresholds for MRFs?
  • Is the introduction of the MetALD category clinically justified?
  • Is it necessary to worry about MRFs in a patient drinking increased or excessive amounts of alcohol and if yes, how should these be accounted for in disease classification systems?


  • Vlad Ratziu (Moderator)
  • Giulio Marchesini (Faculty)
  • Nancy Reau (Faculty)
  • Roberto Vettor (Faculty)

Related article

Related episodes

ℹ️ Please click here to access the podcast version of this EASL Studio episode.

Log in to post comments